Related Experiment Video
Updated: Mar 14, 2026

09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
31.0K
Antivirals against animal viruses
T G Villa1, L Feijoo-Siota1, J L R Rama1
1Department of Microbiology, Biotechnology Unit, Faculty of Pharmacy, University of Santiago de Compostela 15706, Spain.
Biochemical Pharmacology
|October 5, 2016
Summary
This review explores natural and synthetic antivirals, highlighting natural compounds for future drug development. It emphasizes the need for new antiviral strategies due to viral resistance.
Area of Science:
- Pharmacology
- Virology
- Natural Product Chemistry
Background:
- Antivirals, used since the 1960s, combat viral infections by interfering with viral development.
- These compounds originate from natural sources (animals, plants, microbes) or chemical synthesis.
- Viruses' ability to develop resistance necessitates continuous research for novel antiviral agents.
Purpose of the Study:
- To review natural and synthetic antiviral compounds in chronological order.
- To emphasize natural compounds as a basis for future antiviral treatments.
- To explore diverse antiviral mechanisms and their impact on viral replication and host immunity.
Main Methods:
- Literature review of natural and synthetic antivirals.
- Chronological analysis of antiviral discoveries and development.
- Emphasis on natural product-derived antivirals.
Main Results:
- Overview of various antiviral sources and synthesis methods.
- Description of diverse mechanisms of action, including immune enhancement and enzyme inhibition.
- Identification of challenges such as host toxicity and viral resistance.
Conclusions:
- Natural compounds offer a promising foundation for developing novel antiviral therapies.
- Understanding antiviral mechanisms is crucial for effective treatment design.
- Continued research is essential to overcome viral resistance and improve antiviral efficacy.
Related Concept Videos
Subviral Agents
709
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
709
Retrovirus Life Cycles
50.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.2K
Viral Recombination
25.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.5K
Viruses with RNA Genomes
1.2K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.2K
Viral Mutations
40.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.6K

